January 2025 in “Current Drug Delivery” This study found that compounded formulations using TrichoSol™ and TrichoFoam™ vehicles for alopecia treatments maintained stability and were effective for use up to 180 days, suggesting these vehicles are suitable for personalizing hair care solutions without significant degradation or physical changes.
August 2023 in “Scientia Pharmaceutica” In this study, researchers evaluated the stability and color changes of compounded minoxidil formulations used for alopecia, finding that while the formulations remained chemically and microbiologically stable for up to 380 days, significant color changes were observed, which likely do not affect the product's effectiveness.
In this study, researchers assessed the stability of various formulations in the TrichoConcept™ line for customized alopecia treatment. They found that the combinations remained stable from 14 to 180 days, supporting the use of these vehicles for enhancing therapeutic outcomes in hair loss treatments.
In this study, using Trichosol™ with Minoxidil (3%) increased the percentage of hair in the anagen growth phase by about 20% over 90 days compared to using Minoxidil alone.
January 2020 in “Journal of Cosmetics, Dermatological Sciences and Applications” This study concluded that TrichoxidilTM positively affected hair growth by increasing growth factor expression and fibroblast proliferation, suggesting it may be a promising treatment for androgenetic alopecia.